CD8A and neoplasm: First, we compared the generation of antigen-specific CD8+ T cells after i.m. vaccination of tumor-free mice with opt-OVA or EV-opt-OVA to identify the appropriate matching doses, i.e., the viral titer needed to induce comparable immune response.